TLDR Bicalutamide may be a promising alternative treatment for female pattern hair loss.
The article discusses the potential use of bicalutamide, an oral antiandrogenic drug, for the treatment of female pattern hair loss (FPHL). The authors conducted a retrospective review of 44 women receiving bicalutamide for FPHL and found a mild increase in liver transaminases in 11.4% of patients, but no patients discontinued treatment. Other adverse effects included hair shedding, transient amenorrhea, endometrial hyperplasia, and headache. The authors suggest that bicalutamide may be a promising alternative treatment for FPHL, but further studies are needed to confirm its efficacy and safety.
16 citations,
March 2020 in “Journal of The American Academy of Dermatology” Oral bicalutamide is safe and effective for female hair loss.
12 citations,
January 2020 in “Skin appendage disorders” Low-dose oral minoxidil effectively treats female hair loss with good safety.
8 citations,
October 2019 in “Dermatologic Therapy” Bicalutamide improves hair density in women safely.
25 citations,
December 2017 in “The Journal of Clinical Endocrinology & Metabolism” Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.
March 2023 in “Anais Brasileiros De Dermatologia” Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.
September 2024 in “Indian Journal of Dermatology Venereology and Leprology” Mesotherapy with bicalutamide has limited effectiveness for female hair loss.
September 2024 in “Journal of Cutaneous and Aesthetic Surgery” Bicalutamide may help treat female pattern hair loss.
There are many treatments for common hair loss, but more trials are needed to decide which are best.
Nanotechnology shows promise for better hair loss treatments but needs more research for safety and effectiveness.
